World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Improving CAR-T therapy from within

Improving CAR-T therapy from within

by admin | Apr 17, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Sarah Pelta – Stanford Medicine – Could the gut microbiome hold the key to better cancer treatment outcomes? “We send your T cells to boot camp.” That is how hematologist-oncologist and Stanford Cancer Institute member Melody Smith, MD, describes CAR-T...
‘A cure on the horizon’: Are we finally close to ending type 1 diabetes?

‘A cure on the horizon’: Are we finally close to ending type 1 diabetes?

by admin | Apr 16, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Tia Ghose – Live Science – It’s a running joke that a cure for type 1 diabetes is only five years away and has been for 50 years, but new stem cell trials and immune drugs hint that we’re closer than ever to a functional cure for the...
Scientists create “smart” DNA drug that targets cancer cells with extreme precision

Scientists create “smart” DNA drug that targets cancer cells with extreme precision

by admin | Apr 15, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Université de Genève – Science Daily – Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of tumor markers,...
Patient deaths prompt concern over regenerative care not covered by insurance

Patient deaths prompt concern over regenerative care not covered by insurance

by admin | Apr 14, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By The Japan Times – A series of fatal accidents and regulatory violations involving regenerative treatments not covered by insurance have occurred in Japan, prompting health authorities to review related systems. Regenerative medicine, which uses cells or genes...
Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development

Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development

by admin | Apr 13, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Tristan Manalac – BIoSpace – The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence. After hitting a historic low in 2025—only eight biotechs went public, as per...
Clinical trial tests new cell therapy to manage kidney transplant rejection

Clinical trial tests new cell therapy to manage kidney transplant rejection

by admin | Apr 10, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By University of Wisconsin School of Medicine and Public Health – A first-of-its-kind clinical trial at the Program for Advanced Cell Therapy will examine a new method to manage kidney rejection following transplant. The Program for Advanced Cell Therapy, or...
Page 1 of 21612345...102030...»Last »

Recent Posts

  • Improving CAR-T therapy from within
  • ‘A cure on the horizon’: Are we finally close to ending type 1 diabetes?
  • Scientists create “smart” DNA drug that targets cancer cells with extreme precision
  • Patient deaths prompt concern over regenerative care not covered by insurance
  • Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development
  • Clinical trial tests new cell therapy to manage kidney transplant rejection
World Stem Cell Summit Logo - White version
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow